← 產業報告目錄

Medical Humidifier Market by Product (Heated, Heat & Moisture Exchangers, Humidifier Accessories), Application (ICUs , Neonatal Care),Distribution Channel (Online), Patient Type (Adult), End user (Hospitals) and Region - Global Forecast to 2029

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-03-11頁數 294報告編號 MD9325

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global Medical humidifier market is projected to reach USD 1,211.7 million by 2029 from USD 922.8 million in 2024, at a CAGR of 5.6% during the forecast period. This is due to increasing cases of COPD, asthma, sleep apnea, pneumonia, and bronchitis, growing air pollution, smoking, and climate change are worsening respiratory conditions, necessitating humidification therapy, newborns and infants, especially premature babies, require humidified oxygen therapy in neonatal intensive care units (NICUs), and aging populations and rising healthcare costs are driving a shift toward home-based treatments. But recurring costs for maintenance, replacement parts (filters, chambers), and energy consumption add to financial burden, and poor maintenance or improper cleaning can lead to bacterial and mold growth, increasing infection risks. “The heated humidifier segment of medical humidifier market by product to hold largest market share during forecast period.” Based on the product, the medical humidifier market is divided into Heated Humidifier, Bubble Humidifier , Heat and Moisture Exchangers (HMEs), and Humidifier Accessories. Among these, in 2023 heated humidifier segment account for the largest market share of in medical humidifier market. This is due to the increasing use of Heated humidifiers in mechanical ventilation, oxygen therapy, and non-invasive ventilation (NIV) to prevent airway dryness and irritation, rising geriatric population who are more prone to respiratory conditions, and regulatory support from the US Food and Drug Administration (FDA), Conformité Européene (CE) (Europe), and other global bodies ensures product quality and drives market confidence. “The intensive care unit (ICU) segment of medical humidifier market by application to hold largest market share during the forecast period.” Based on application, the medical humidifier market is segmented into Intensive Care Unit (ICU), Neonatal Care, Respiratory Therapy, and Other Applications. The intensive care unit (ICU) segment accounts for the largest market share in medical humidifier market due to increasing hospitalizations due to severe respiratory diseases, pneumonia, and post-surgical recovery, premature infants require respiratory support with humidified oxygen in neonatal intensive care units (NICUs), and public and private healthcare investments in ICU capacity expansion are increasing humidifier adoption. Moreover, The pandemic highlighted the need for advanced ICU humidification systems for ventilated patients. “Asia Pacific to hold the highest CAGR of the medical humidifier market by region.” The global medical humidifier market is segmented into six major regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. Asia Pacific is estimated to grow at the highest CAGR during the forecast period. This is attributed to an aging population and chronic disease management at home. Japan, South Korea, and China's aging populations are more likely to develop respiratory problems and require ICU admissions. The governments of China, India, Japan, and Southeast Asia are investing in ICU growth to improve critical care. Low-birth-weight and premature babies often suffer with respiratory problems and need humidified oxygen therapy. The OECD estimates that the average neonatal mortality rate in lower-middle- and low-income APAC countries in 2022 will be 15.6 deaths per 1,000 live births. Japan, China, India, Australia, and the rest of Asia Pacific comprise the region. In the medical humidifier market in 2023 China boasts the highest market share. This is ascribed to China's aging population, rising awareness, investments in healthcare facilities, and rising frequency of respiratory diseases including COPD and asthma. With more than 280 million individuals aged 60 and above as of the end of 2022, or 19.8% of the whole population, China has the highest aging population worldwide. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1–30%, Tier 2–46%, and Tier 3– 24% • By Designation: C-level–25%, Director-level–35% and Others–40% • By Region: North America–40%, Europe–25%, Asia Pacific–19%, Latin America- 8%, Middle east and Africa – 6%, and GCC Countries – 2 % Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1.0 billion, Tier 2 = USD 500.0 million to USD 1.0 billion, and Tier 3 = <USD 500.0 million. Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs. Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers. The major players operating in the medical humidifier market are include ResMed Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Koninklijke Philips N.V. (Netherlands), Vincent Medical Holdings Limited (Hong Kong), Medline Industries, LP. (US), Hamilton Medical (Switzerland), GaleMed Corporation (Taiwan), and Eakin Healthcare (UK). Research Coverage This report studies the medical humidifier market based on product, application, distribution channel, patient type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions). Reasons to Buy the Report The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence. This report provides insights on the following pointers: • Analysis of Key divers (Rising use of medical humidifiers in ventilation therapy, Increasing prevalence of respiratory diseases, Rising incidence of premature births and advances in neonatal care, Rapid growth in geriatric population), restraints (Frequent replacement of disposable components, increasing operational costs, Low awareness of the threat of respiratory diseases), Challenge (Risk of infectious due to improper maintenance, High cost of advanced humidifiers to limit adoption), opportunity (Post-pandemic demand for respiratory care, Government and non-government initiatives in respiratory health, Increasing investments in hospital infrastructure in emerging markets) • Market Penetration: Complete knowledge on the spectrum of products presented by the major companies in the medical humidifier market • Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and new products introductions within the medical humidifier market • Market Development: Complete knowledge about profitable developing regions • Market Diversification: Exhaustive knowledge on new goods, expanding geographies, and current changes in the medical humidifier industry helps to diversify the market • Competitive Assessment: Comprehensive evaluation of market segmentation, development plans, income analysis, and goods of the top market participants.
目錄 Table of Contents
1 INTRODUCTION 25 1.1 STUDY OBJECTIVES 25 1.2 MARKET DEFINITION 25 1.3 STUDY SCOPE 26 1.3.1 MARKETS COVERED & REGIONS CONSIDERED 26 1.3.2 INCLUSIONS & EXCLUSIONS 27 1.3.3 YEARS CONSIDERED 27 1.3.4 CURRENCY CONSIDERED 28 1.4 STAKEHOLDERS 28 1.4.1 IMPACT OF AI/GENERATIVE AI 28 2 RESEARCH METHODOLOGY 29 2.1 RESEARCH DATA 29 2.1.1 SECONDARY DATA 30 2.1.1.1 Key data from secondary sources 31 2.1.2 PRIMARY DATA 32 2.1.2.1 Primary sources 32 2.1.2.2 Key data from primary sources 33 2.1.2.3 Key industry insights 34 2.1.2.4 Breakdown of primary interviews 34 2.2 MARKET SIZE ESTIMATION 35 2.2.1 BOTTOM-UP APPROACH 35 2.2.1.1 Approach 1: Company revenue estimation approach 36 2.2.1.2 Approach 2: Presentations of companies and primary interviews 36 2.2.1.3 Growth forecast 37 2.2.1.4 CAGR projections 37 2.2.2 TOP-DOWN APPROACH 38 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39 2.4 MARKET SHARE ASSESSMENT 40 2.5 RESEARCH ASSUMPTIONS 40 2.6 STUDY LIMITATIONS 41 2.7 GROWTH RATE ASSUMPTIONS 41 2.8 RISK ASSESSMENT 41 3 EXECUTIVE SUMMARY 42   4 PREMIUM INSIGHTS 47 4.1 MEDICAL HUMIDIFIER MARKET OVERVIEW 47 4.2 ASIA PACIFIC MEDICAL HUMIDIFIER MARKET SHARE, BY APPLICATION AND COUNTRY 48 4.3 MEDICAL HUMIDIFIER MARKET, BY COUNTRY 49 4.4 MEDICAL HUMIDIFIER MARKET, REGIONAL MIX, 2024 VS. 2029 50 4.5 MEDICAL HUMIDIFIER MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS 50 5 MARKET OVERVIEW 51 5.1 INTRODUCTION 51 5.2 MARKET DYNAMICS 51 5.2.1 DRIVERS 52 5.2.1.1 Rising use of medical humidifiers in ventilation therapy 52 5.2.1.2 Increasing prevalence of respiratory diseases 53 5.2.1.3 Rising incidence of premature births and advances in neonatal care 54 5.2.1.4 Rapid growth in geriatric population 55 5.2.2 RESTRAINTS 56 5.2.2.1 Frequent replacement of disposable components, increasing operational costs 56 5.2.2.2 Low awareness of threat of respiratory diseases 57 5.2.3 OPPORTUNITIES 57 5.2.3.1 Post-pandemic demand for respiratory care 57 5.2.3.2 Government and non-government initiatives in respiratory health 58 5.2.3.3 Increasing investments in hospital infrastructure in emerging markets 59 5.2.4 CHALLENGES 60 5.2.4.1 Risk of infections due to improper maintenance 60 5.2.4.2 High cost of advanced humidifiers to limit adoption 61 5.3 PRICING ANALYSIS 61 5.3.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 61 5.3.2 AVERAGE SELLING PRICE TREND, BY REGION 62 5.3.3 AVERAGE SELLING PRICE TREND, BY PRODUCT 63 5.4 VALUE CHAIN ANALYSIS 64 5.4.1 RESEARCH & DEVELOPMENT (R&D) 64 5.4.2 MANUFACTURING 64 5.4.3 DISTRIBUTION AND MARKETING & SALES 64 5.4.4 POST-SALES SERVICES 64 5.5 SUPPLY CHAIN ANALYSIS 65 5.5.1 PROMINENT COMPANIES 65 5.5.2 SMALL AND MEDIUM-SIZED ENTERPRISES 65 5.5.3 END USERS 66 5.6 ECOSYSTEM ANALYSIS 66 5.7 REGULATORY LANDSCAPE 68 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68 5.7.2 REGULATORY FRAMEWORK 70 5.7.2.1 North America 70 5.7.2.1.1 US 70 5.7.2.1.2 Canada 71 5.7.2.2 Europe 72 5.7.2.3 Asia Pacific 73 5.7.2.3.1 China 73 5.7.2.3.2 Japan 74 5.7.2.3.3 India 75 5.7.2.4 Latin America 75 5.7.2.4.1 Brazil 75 5.8 PATENT ANALYSIS 75 5.9 TRADE ANALYSIS 77 5.9.1 IMPORT DATA FOR HS CODE 901920 78 5.9.2 EXPORT DATA FOR HS CODE 901920 78 5.10 KEY CONFERENCES & EVENTS, 2025–2026 79 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80 5.12 TECHNOLOGY ANALYSIS 81 5.12.1 KEY TECHNOLOGIES 81 5.12.1.1 Heating technology 81 5.12.2 COMPLEMENTARY TECHNOLOGIES 81 5.12.2.1 Bubble diffusion technology 81 5.13 PORTER’S FIVE FORCES ANALYSIS 82 5.13.1 THREAT OF NEW ENTRANTS 83 5.13.2 THREAT OF SUBSTITUTES 84 5.13.3 BARGAINING POWER OF SUPPLIERS 84 5.13.4 BARGAINING POWER OF BUYERS 84 5.13.5 INTENSITY OF COMPETITIVE RIVALRY 84 5.14 KEY STAKEHOLDERS & BUYING CRITERIA 84 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 84 5.14.2 BUYING CRITERIA 85 5.15 INVESTMENT & FUNDING SCENARIO 86 5.16 IMPACT OF AI/GENERATIVE AI ON MEDICAL HUMIDIFIER MARKET 87 5.16.1 INTRODUCTION 87 5.16.2 AI USE CASES 88 5.16.3 AI IN MEDICAL HUMIDIFIERS 88   6 MEDICAL HUMIDIFIER MARKET, BY PRODUCT 90 6.1 INTRODUCTION 91 6.2 HEATED HUMIDIFIERS 91 6.2.1 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET 91 6.3 HEAT & MOISTURE EXCHANGERS 94 6.3.1 RISING DEMAND FOR COST-EFFECTIVE AND DISPOSABLE HMES TO DRIVE MARKET 94 6.4 BUBBLE HUMIDIFIERS 97 6.4.1 TECHNOLOGICAL ADVANCEMENTS IN HUMIDIFICATION SYSTEMS TO PROPEL MARKET GROWTH 97 6.5 HUMIDIFIER ACCESSORIES 100 6.5.1 INCREASED REPLACEMENT FREQUENCY OF ACCESSORIES TO FUEL DEMAND 100 7 MEDICAL HUMIDIFIER MARKET, BY APPLICATION 104 7.1 INTRODUCTION 105 7.2 INTENSIVE CARE UNITS 105 7.2.1 INCREASE IN ICU ADMISSIONS TO DRIVE MARKET GROWTH 105 7.3 NEONATAL CARE 108 7.3.1 RISING PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO DRIVE MARKET 108 7.4 RESPIRATORY THERAPY 112 7.4.1 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE DEMAND 112 7.5 OTHER APPLICATIONS 115 8 MEDICAL HUMIDIFIER MARKET, DISTRIBUTION CHANNEL 118 8.1 INTRODUCTION 119 8.2 HOSPITAL PHARMACIES 119 8.2.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS AND BULK PURCHASES OF MEDICAL HUMIDIFIERS TO DRIVE MARKET 119 8.3 RETAIL PHARMACIES 122 8.3.1 RISING DEMAND FOR HOME-BASED RESPIRATORY CARE SOLUTIONS TO DRIVE MARKET 122 8.4 ONLINE PHARMACIES 124 8.4.1 RISE IN E-COMMERCE ADOPTION AND DIGITAL TRANSFORMATION IN HEALTHCARE TO SUPPORT MARKET GROWTH 124 9 MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE 128 9.1 INTRODUCTION 129 9.2 ADULT PATIENTS 129 9.2.1 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE THE MARKET 129 9.3 NEONATAL PATIENTS 133 9.3.1 RISE IN PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO PROPEL MARKET GROWTH 133 9.4 PEDIATRIC PATIENTS 136 9.4.1 RISE IN PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO PROPEL GROWTH 136 10 MEDICAL HUMIDIFIER MARKET, BY END USER 140 10.1 INTRODUCTION 141 10.2 HOSPITALS & AMBULATORY SURGERY CENTERS 141 10.2.1 RISING NUMBER OF ICU ADMISSIONS AND PREFERENCE FOR AMBULATORY SURGERY TO DRIVE DEMAND 141 10.3 HOME CARE SETTINGS 144 10.3.1 RISING ELDERLY POPULATION TO DRIVE DEMAND FOR HOME-USE DEVICES 144 10.4 SPECIALTY CLINICS 147 10.4.1 INCREASING PREVALENCE OF CHRONIC RESPIRATORY DISORDERS TO DRIVE MARKET 147 10.5 OTHER END USERS 150 11 MEDICAL HUMIDIFIER MARKET, BY REGION 154 11.1 INTRODUCTION 155 11.2 NORTH AMERICA 155 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 156 11.2.2 US 160 11.2.2.1 Rising premature births and advances in neonatal care to drive market 160 11.2.3 CANADA 163 11.2.3.1 Increasing prevalence of respiratory diseases to drive market 163 11.3 EUROPE 167 11.3.1 EUROPE: MACROECONOMIC OUTLOOK 168 11.3.2 GERMANY 171 11.3.2.1 Increasing public healthcare expenditure to foster market growth 171 11.3.3 UK 174 11.3.3.1 Increasing incidence of respiratory conditions such as COPD and asthma to drive market 174 11.3.4 FRANCE 178 11.3.4.1 High prevalence of COPD to surge demand 178 11.3.5 ITALY 181 11.3.5.1 Increasing geriatric population to support demand for humidifiers 181 11.3.6 SPAIN 184 11.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand 184 11.3.7 REST OF EUROPE 187   11.4 ASIA PACIFIC 190 11.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 191 11.4.2 CHINA 195 11.4.2.1 Growing elderly demographic to propel market 195 11.4.3 JAPAN 198 11.4.3.1 High prevalence of respiratory diseases to drive market growth 198 11.4.4 INDIA 201 11.4.4.1 Expanding healthcare infrastructure to drive demand 201 11.4.5 AUSTRALIA 205 11.4.5.1 High prevalence of COPD & asthma to drive market growth 205 11.4.6 REST OF ASIA PACIFIC 208 11.5 LATIN AMERICA 212 11.5.1 HIGH NEONATAL MORTALITY RATE TO DRIVE MARKET 212 11.5.2 LATIN AMERICA: MACROECONOMIC OUTLOOK 213 11.6 MIDDLE EAST & AFRICA 216 11.6.1 PRESENCE OF UNSATURATED MARKETS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS 216 11.6.2 MIDDLE EAST &AFRICA: MACROECONOMIC OUTLOOK 217 11.7 GCC COUNTRIES 220 11.7.1 SIGNIFICANT INVESTMENTS IN DEVELOPMENT AND EXPANSION OF HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET 220 11.7.2 GCC COUNTRIES: MACROECONOMIC OUTLOOK 222 12 COMPETITIVE LANDSCAPE 225 12.1 OVERVIEW 225 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 225 12.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 226 12.4 REVENUE ANALYSIS, 2021–2023 227 12.5 MARKET SHARE ANALYSIS, 2023 228 12.5.1 RANKING OF KEY MARKET PLAYERS 229 12.6 COMPANY SHARE ANALYSIS, BY PRODUCT 230 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 232 12.7.1 STARS 232 12.7.2 EMERGING LEADERS 232 12.7.3 PERVASIVE PLAYERS 232 12.7.4 PARTICIPANTS 232 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 234 12.7.5.1 Company footprint 234 12.7.5.2 Region footprint 235 12.7.5.3 Product footprint 236 12.7.5.4 Application footprint 236 12.7.5.5 End-user footprint 237   12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 237 12.8.1 PROGRESSIVE COMPANIES 237 12.8.2 RESPONSIVE COMPANIES 237 12.8.3 DYNAMIC COMPANIES 238 12.8.4 STARTING BLOCKS 238 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 239 12.8.5.1 Detailed list of key startups/SMEs 239 12.8.5.2 Competitive benchmarking of key emerging players/startups 239 12.9 COMPANY VALUATION & FINANCIAL METRICS 240 12.9.1 FINANCIAL METRICS 240 12.9.2 COMPANY VALUATION 240 12.10 BRAND/PRODUCT COMPARISON 241 12.11 COMPETITIVE SCENARIO 242 12.11.1 PRODUCT LAUNCHES 242 12.11.2 DEALS 242 12.11.3 EXPANSIONS 243 13 COMPANY PROFILES 244 13.1 KEY PLAYERS 244 13.1.1 FISHER & PAYKEL HEALTHCARE LIMITED 244 13.1.1.1 Business overview 244 13.1.1.2 Products offered 246 13.1.1.3 Recent developments 247 13.1.1.3.1 Product launches 247 13.1.1.3.2 Expansions 247 13.1.1.4 MnM view 247 13.1.1.4.1 Key strengths 247 13.1.1.4.2 Strategic choices made 248 13.1.1.4.3 Weaknesses and competitive threats 248 13.1.2 RESMED INC. 249 13.1.2.1 Business overview 249 13.1.2.2 Products offered 250 13.1.2.3 MnM view 251 13.1.2.3.1 Key strengths 251 13.1.2.3.2 Strategic choices made 251 13.1.2.3.3 Weaknesses and competitive threats 251 13.1.3 DRÄGERWERK AG & CO. KGAA 252 13.1.3.1 Business overview 252 13.1.3.2 Products offered 254 13.1.3.3 MnM view 254 13.1.3.3.1 Key strengths 254 13.1.3.3.2 Strategic choices made 255 13.1.3.3.3 Weaknesses and competitive threats 255 13.1.4 KONINKLIJKE PHILIPS N.V. 256 13.1.4.1 Business overview 256 13.1.4.2 Products offered 258 13.1.5 VINCENT MEDICAL HOLDINGS LIMITED 259 13.1.5.1 Business overview 259 13.1.5.2 Products offered 261 13.1.5.3 Recent developments 261 13.1.5.3.1 Expansions 261 13.1.6 MEDLINE INDUSTRIES, LP. 262 13.1.6.1 Business overview 262 13.1.6.2 Products offered 262 13.1.6.3 Recent developments 263 13.1.6.3.1 Deals 263 13.1.6.3.2 Expansions 265 13.1.7 HAMILTON MEDICAL 266 13.1.7.1 Business overview 266 13.1.7.2 Products offered 266 13.1.7.3 Recent developments 267 13.1.7.3.1 Expansions 267 13.1.8 GALEMED CORPORATION 268 13.1.8.1 Business overview 268 13.1.8.2 Products offered 268 13.1.8.3 Recent developments 269 13.1.8.3.1 Product launches 269 13.1.9 EAKIN HEALTHCARE 270 13.1.9.1 Business overview 270 13.1.9.2 Products offered 270 13.2 OTHER PLAYERS 271 13.2.1 VADI MEDICAL TECHNOLOGY CO., LTD. 271 13.2.2 SHENYANG RMS MEDICAL TECH CO., LTD 272 13.2.3 FLEXICARE (GROUP) LIMITED 273 13.2.4 BESMED HEALTH BUSINESS CORP 274 13.2.5 LÖWENSTEIN MEDICAL SE & CO. KG 275 13.2.6 INTERSURGICAL 276 13.2.7 PRECISION MEDICAL, INC. 277 13.2.8 DRIVE DEVILBISS INTERNATIONAL 277 13.2.9 NEOKRAFT MEDICAL PVT. LTD. 278 13.2.10 DYNAREX CORPORATION 279 13.2.11 HSI LLC. 280 13.2.12 TRUDELL MEDICAL LIMITED 281 13.2.13 GREAT GROUP MEDICAL CO., LTD. 282 13.2.14 FANEM 283 13.2.15 HEYER MEDICAL AG 283 13.2.16 BIOSYS 284 14 APPENDIX 285 14.1 DISCUSSION GUIDE 285 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 290 14.3 CUSTOMIZATION OPTIONS 292 14.4 RELATED REPORTS 292 14.5 AUTHOR DETAILS 293
圖表清單 List of Tables & Figures
TABLE 1 RISK ASSESSMENT: MEDICAL HUMIDIFIER MARKET 41 TABLE 2 US: MORTALITY RATE OF RESPIRATORY DISORDERS 53 TABLE 3 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2023–2025 (USD) 62 TABLE 4 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2023–2025 (USD) 63 TABLE 5 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TYPE, 2023–2025 63 TABLE 6 MEDICAL HUMIDIFIER MARKET: ROLE OF COMPANIES IN ECOSYSTEM 67 TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68 TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION 70 TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 71 TABLE 14 ISO: INTEGRATION WITH OTHER EQUIPMENT 72 TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72 TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES 73 TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 74 TABLE 18 MEDICAL HUMIDIFIER MARKET: INNOVATIONS AND PATENT REGISTRATIONS, JANUARY 2022− FEBRUARY 2025 77 TABLE 19 IMPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019–2023 (USD THOUSAND) 78 TABLE 20 EXPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019–2023 (USD THOUSAND) 78 TABLE 21 MEDICAL HUMIDIFIER MARKET: KEY CONFERENCES & EVENTS, 2025−2026 79 TABLE 22 MEDICAL HUMIDIFIER MARKET: PORTER’S FIVE FORCES ANALYSIS 82 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MEDICAL HUMIDIFIERS, BY END USER (%) 85 TABLE 24 KEY BUYING CRITERIA FOR MEDICAL HUMIDIFIERS, BY END USER 86 TABLE 25 MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 91 TABLE 26 KEY HEATED HUMIDIFIERS OFFERED, BY COMPANY 92 TABLE 27 HEATED HUMIDIFIERS MARKET, BY REGION, 2022–2029 (USD MILLION) 92 TABLE 28 HEATED HUMIDIFIER MARKET, BY REGION, 2022–2029 (THOUSAND UNITS) 93 TABLE 29 NORTH AMERICA: HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 93 TABLE 30 EUROPE: HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 93 TABLE 31 ASIA PACIFIC: HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 94 TABLE 32 KEY HEAT & MOISTURE EXCHANGERS OFFERED, BY COMPANY 95 TABLE 33 HEAT & MOISTURE EXCHANGERS MARKET, BY REGION, 2022–2029 (USD MILLION) 95 TABLE 34 NORTH AMERICA: HEAT & MOISTURE EXCHANGERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 96 TABLE 35 EUROPE: HEAT & MOISTURE EXCHANGERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 96 TABLE 36 ASIA PACIFIC: HEAT & MOISTURE EXCHANGERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 97 TABLE 37 KEY BUBBLE HUMIDIFIERS OFFERED, BY COMPANY 98 TABLE 38 BUBBLE HUMIDIFIERS MARKET, BY REGION, 2022–2029 (USD MILLION) 98 TABLE 39 NORTH AMERICA: BUBBLE HUMIDIFIERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 99 TABLE 40 EUROPE: BUBBLE HUMIDIFIERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 99 TABLE 41 ASIA PACIFIC: BUBBLE HUMIDIFIERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 100 TABLE 42 KEY HUMIDIFIER ACCESSORIES OFFERED, BY COMPANY 101 TABLE 43 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 101 TABLE 44 NORTH AMERICA: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 102 TABLE 45 EUROPE: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 102 TABLE 46 ASIA PACIFIC: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 103 TABLE 47 MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 105 TABLE 48 NUMBER OF ICU BEDS, BY COUNTRY (2024) 106 TABLE 49 MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS, BY REGION, 2022–2029 (USD MILLION) 106 TABLE 50 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS, BY COUNTRY, 2022–2029 (USD MILLION) 107 TABLE 51 EUROPE: MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS, BY COUNTRY, 2022–2029 (USD MILLION) 107 TABLE 52 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS, BY COUNTRY, 2022–2029 (USD MILLION) 108 TABLE 53 NEONATAL MORTALITY RATES, BY COUNTRY (2022) 109 TABLE 54 MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE, BY REGION, 2022–2029 (USD MILLION) 110 TABLE 55 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE, BY COUNTRY, 2022–2029 (USD MILLION) 110 TABLE 56 EUROPE: MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE, BY COUNTRY, 2022–2029 (USD MILLION) 111 TABLE 57 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE, BY COUNTRY, 2022–2029 (USD MILLION) 111 TABLE 58 MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY, BY REGION, 2022–2029 (USD MILLION) 113 TABLE 59 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY, BY COUNTRY, 2022–2029 (USD MILLION) 113 TABLE 60 EUROPE: MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY, BY COUNTRY, 2022–2029 (USD MILLION) 114 TABLE 61 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY, BY COUNTRY, 2022–2029 (USD MILLION) 114 TABLE 62 MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 116 TABLE 63 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 116 TABLE 64 EUROPE: MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 117 TABLE 65 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 117 TABLE 66 MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 119 TABLE 67 MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2022–2029 (USD MILLION) 120 TABLE 68 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 120 TABLE 69 EUROPE: MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 121 TABLE 70 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 121 TABLE 71 MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES, BY REGION, 2022–2029 (USD MILLION) 123 TABLE 72 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 123 TABLE 73 EUROPE: MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 124 TABLE 74 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 124 TABLE 75 MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES, BY REGION, 2022–2029 (USD MILLION) 125 TABLE 76 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 126 TABLE 77 EUROPE: MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 126 TABLE 78 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 127 TABLE 79 MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 129 TABLE 80 MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS, BY REGION, 2022–2029 (USD MILLION) 131 TABLE 81 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 131 TABLE 82 EUROPE: MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 132 TABLE 83 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 132 TABLE 84 NUMBER OF NEONATAL DEATHS (2022) 133 TABLE 85 MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS, BY REGION, 2022–2029 (USD MILLION) 134 TABLE 86 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 135 TABLE 87 EUROPE: MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 135 TABLE 88 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 136 TABLE 89 MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2022–2029 (USD MILLION) 138 TABLE 90 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 138 TABLE 91 EUROPE: MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 139 TABLE 92 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 139 TABLE 93 MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 141 TABLE 94 MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS, BY REGION, 2022–2029 (USD MILLION) 143 TABLE 95 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2022–2029 (USD MILLION) 143 TABLE 96 EUROPE: MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2022–2029 (USD MILLION) 144 TABLE 97 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2022–2029 (USD MILLION) 144 TABLE 98 MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD MILLION) 145 TABLE 99 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 146 TABLE 100 EUROPE: MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 146 TABLE 101 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 147 TABLE 102 MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS, BY REGION, 2022–2029 (USD MILLION) 148 TABLE 103 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 149 TABLE 104 EUROPE: MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 149 TABLE 105 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 150 TABLE 106 MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 152 TABLE 107 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 152 TABLE 108 EUROPE: MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 153 TABLE 109 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 153 TABLE 110 MEDICAL HUMIDIFIER MARKET, BY REGION, 2022–2029 (USD MILLION) 155 TABLE 111 NORTH AMERICA: MACROECONOMIC INDICATORS 156 TABLE 112 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157 TABLE 113 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 158 TABLE 114 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 158 TABLE 115 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 159 TABLE 116 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 159 TABLE 117 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 159 TABLE 118 US: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 161 TABLE 119 US: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 162 TABLE 120 US: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 162 TABLE 121 US: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 162 TABLE 122 US: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 163 TABLE 123 CANADA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 165 TABLE 124 CANADA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 165 TABLE 125 CANADA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 166 TABLE 126 CANADA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 166 TABLE 127 CANADA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 166 TABLE 128 EUROPE: KEY MACROINDICATORS 168 TABLE 129 EUROPE: MEDICAL HUMIDIFIER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 169 TABLE 130 EUROPE: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 169 TABLE 131 EUROPE: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 170 TABLE 132 EUROPE: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 170 TABLE 133 EUROPE: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 170 TABLE 134 EUROPE: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 171 TABLE 135 GERMANY: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 172 TABLE 136 GERMANY: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 173 TABLE 137 GERMANY: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 173 TABLE 138 GERMANY: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 173 TABLE 139 GERMANY: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 174 TABLE 140 UK: MORTALITY FROM RESPIRATORY DISEASE, 2018–2023 (ALL AGES) 175 TABLE 141 UK: NUMBER OF PEOPLE RECEIVING DOMICILIARY CARE (HOME CARE) BY NATION 175 TABLE 142 UK: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 176 TABLE 143 UK: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 176 TABLE 144 UK: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 177 TABLE 145 UK: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 177 TABLE 146 UK: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 177 TABLE 147 FRANCE: RESPIRATORY DISEASE PREVALENCE, MORTALITY, AND COST, BY TYPE (2021) 178 TABLE 148 FRANCE: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 179 TABLE 149 FRANCE: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 179 TABLE 150 FRANCE: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 180 TABLE 151 FRANCE: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 180 TABLE 152 FRANCE: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 180 TABLE 153 ITALY: RESPIRATORY DISEASE PREVALENCE, MORTALITY, AND COST, BY TYPE (2021) 181 TABLE 154 ITALY: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 182 TABLE 155 ITALY: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 183 TABLE 156 ITALY: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 183 TABLE 157 ITALY: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 183 TABLE 158 ITALY: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 184 TABLE 159 SPAIN: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 185 TABLE 160 SPAIN: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 186 TABLE 161 SPAIN: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 186 TABLE 162 SPAIN: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 186 TABLE 163 SPAIN: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 187 TABLE 164 REST OF EUROPE: MORTALITY RATE OF RESPIRATORY DISEASES (2021) 188 TABLE 165 REST OF EUROPE: NEONATE MORTALITY RATE (2022) 188 TABLE 166 REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 189 TABLE 167 REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 189 TABLE 168 REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 189 TABLE 169 REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 190 TABLE 170 REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 190 TABLE 171 ASIA & PACIFIC: KEY MACROINDICATORS 191 TABLE 172 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 193 TABLE 173 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 193 TABLE 174 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 194 TABLE 175 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 194 TABLE 176 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 194 TABLE 177 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 195 TABLE 178 CHINA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 196 TABLE 179 CHINA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 196 TABLE 180 CHINA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 197 TABLE 181 CHINA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 197 TABLE 182 CHINA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 197 TABLE 183 JAPAN: LEADING CAUSES OF DEATH (2021) 198 TABLE 184 JAPAN: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 199 TABLE 185 JAPAN: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 200 TABLE 186 JAPAN: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 200 TABLE 187 JAPAN: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 200 TABLE 188 JAPAN: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 201 TABLE 189 INDIA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 203 TABLE 190 INDIA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 203 TABLE 191 INDIA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 204 TABLE 192 INDIA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 204 TABLE 193 INDIA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 204 TABLE 194 AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 207 TABLE 195 AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 207 TABLE 196 AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 207 TABLE 197 AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 208 TABLE 198 AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 208 TABLE 199 REST OF ASIA PACIFIC: MORTALITY IN CHILDREN UNDER 5 YEARS (2022) 209 TABLE 200 REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 210 TABLE 201 REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 210 TABLE 202 REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 211 TABLE 203 REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 211 TABLE 204 REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 211 TABLE 205 LATIN AMERICA: NEONATAL MORTALITY RATE (2022) 212 TABLE 206 LATIN AMERICA & CARIBBEAN: KEY MACROINDICATORS 213 TABLE 207 LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 214 TABLE 208 LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 214 TABLE 209 LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 215 TABLE 210 LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 215 TABLE 211 LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 215 TABLE 212 MIDDLE EAST & AFRICA: NEONATAL MORTALITY RATE (2022) 217 TABLE 213 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 217 TABLE 214 MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 218 TABLE 215 MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 218 TABLE 216 MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 219 TABLE 217 MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 219 TABLE 218 MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 219 TABLE 219 GCC COUNTRIES: NEONATAL MORTALITY (2022) 221 TABLE 220 GCC COUNTRIES: KEY MACROINDICATORS 222 TABLE 221 GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 222 TABLE 222 GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 223 TABLE 223 GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 223 TABLE 224 GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 223 TABLE 225 GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION) 224 TABLE 226 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MEDICAL HUMIDIFIERS MARKET PLAYERS, JANUARY 2022–FEBRUARY 2025 226 TABLE 227 MEDICAL HUMIDIFIER MARKET: DEGREE OF COMPETITION 228 TABLE 228 MEDICAL HUMIDIFIER MARKET: REGION FOOTPRINT 235 TABLE 229 MEDICAL HUMIDIFIER MARKET: PRODUCT FOOTPRINT 236 TABLE 230 MEDICAL HUMIDIFIER MARKET: APPLICATION FOOTPRINT 236 TABLE 231 MEDICAL HUMIDIFIER MARKET: END-USER FOOTPRINT 237 TABLE 232 MEDICAL HUMIDIFIER MARKET: DETAILED LIST OF KEY STARTUPS/SMES 239 TABLE 233 MEDICAL HUMIDIFIER MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 239 TABLE 234 MEDICAL HUMIDIFIER MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–FEBRUARY 2025 242 TABLE 235 MEDICAL HUMIDIFIER MARKET: DEALS, JANUARY 2022–FEBRUARY 2025 242 TABLE 236 MEDICAL HUMIDIFIER MARKET: EXPANSIONS, JANUARY 2022–FEBRUARY 2025 243 TABLE 237 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW 244 TABLE 238 FISHER & PAYKEL HEALTHCARE LIMITED: CURRENCY CONVERSION 245 TABLE 239 FISHER & PAYKEL HEALTHCARE LIMITED.: PRODUCTS OFFERED 246 TABLE 240 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES, JANUARY 2022–JANUARY 2025 247 TABLE 241 FISHER & PAYKEL HEALTHCARE LIMITED: EXPANSIONS, JANUARY 2022–JANUARY 2025 247 TABLE 242 RESMED INC.: COMPANY OVERVIEW 249 TABLE 243 RESMED INC.: PRODUCTS OFFERED 250 TABLE 244 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 252 TABLE 245 DRÄGERWERK AG & CO. KGAA: CURRENCY CONVERSION 253 TABLE 246 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 254 TABLE 247 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 256 TABLE 248 KONINKLIJKE PHILIPS N.V.: CURRENCY CONVERSION (EURO TO USD) 257 TABLE 249 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 258 TABLE 250 VINCENT MEDICAL HOLDINGS LIMITED: COMPANY OVERVIEW 259 TABLE 251 VINCENT MEDICAL HOLDINGS LIMITED: CURRENCY CONVERSION (EURO TO USD) 260 TABLE 252 VINCENT MEDICAL HOLDINGS LIMITED: PRODUCTS OFFERED 261 TABLE 253 VINCENT MEDICAL HOLDINGS LIMITED: EXPANSIONS, JANUARY 2022–JANUARY 2025 261 TABLE 254 MEDLINE INDUSTRIES, LP.: COMPANY OVERVIEW 262 TABLE 255 MEDLINE INDUSTRIES, LP.: PRODUCTS OFFERED 262 TABLE 256 MEDLINE INDUSTRIES, LP.: DEALS, JANUARY 2022–JANUARY 2025 263 TABLE 257 MEDLINE INDUSTRIES, LP.: EXPANSIONS, JANUARY 2022–JANUARY 2025 265 TABLE 258 HAMILTON MEDICAL: COMPANY OVERVIEW 266 TABLE 259 HAMILTON MEDICAL: PRODUCTS OFFERED 266 TABLE 260 HAMILTON MEDICAL: EXPANSIONS, JANUARY 2022–JANUARY 2025 267 TABLE 261 GALEMED CORPORATION: COMPANY OVERVIEW 268 TABLE 262 GALEMED CORPORATION: PRODUCTS OFFERED 268 TABLE 263 GALEMED CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JANUARY 2025 269 TABLE 264 EAKIN HEALTHCARE: COMPANY OVERVIEW 270 TABLE 265 EAKIN HEALTHCARE: PRODUCTS OFFERED 270 _ FIGURE 1 MEDICAL HUMIDIFIER MARKET: RESEARCH DESIGN 29 FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 34 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 35 FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 36 FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37 FIGURE 6 TOP-DOWN APPROACH 38 FIGURE 7 DATA TRIANGULATION 39 FIGURE 8 MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 42 FIGURE 9 MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 43 FIGURE 10 MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD MILLION) 43 FIGURE 11 MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2024 VS. 2029 (USD MILLION) 44 FIGURE 12 MEDICAL HUMIDIFIER MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 45 FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MEDICAL HUMIDIFIER MARKET 46 FIGURE 14 INCREASING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE THE MARKET 47 FIGURE 15 INTENSIVE CARE UNITS ACCOUNTED FOR LARGEST SHARE IN 2023 48 FIGURE 16 CHINA TO RECORD HIGHEST GROWTH RATE FROM 2024 TO 2029 49 FIGURE 17 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 50 FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 50 FIGURE 19 MEDICAL HUMIDIFIER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 FIGURE 20 MEDICAL HUMIDIFIER MARKET: VALUE CHAIN ANALYSIS 65 FIGURE 21 MEDICAL HUMIDIFIER MARKET: SUPPLY CHAIN ANALYSIS 66 FIGURE 22 MEDICAL HUMIDIFIER MARKET: ECOSYSTEM ANALYSIS 67 FIGURE 23 MEDICAL HUMIDIFIER MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024 76 FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80 FIGURE 25 MEDICAL HUMIDIFIER MARKET: PORTER’S FIVE FORCES ANALYSIS 83 FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MEDICAL HUMIDIFIERS, BY END USER 85 FIGURE 27 KEY BUYING CRITERIA FOR MEDICAL HUMIDIFIERS, BY END USER 86 FIGURE 28 MEDICAL HUMIDIFIER MARKET: INVESTMENT & FUNDING SCENARIO 2022−2024 87 FIGURE 29 US: NUMBER OF RESPIRATORY THERAPISTS 112 FIGURE 30 US: TRENDS IN COPD, BY AGE 130 FIGURE 31 US: PRETERM BIRTH RATE, 2018–2023 134 FIGURE 32 UK AND IRELAND: ADMISSIONS TO PEDIATRIC INTENSIVE CARE UNITS, 2020–2022 137 FIGURE 33 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET SNAPSHOT 157 FIGURE 34 US: INFANT MORTALITY RATE (2021 & 2022) 160 FIGURE 35 CANADA: DEATHS RELATED TO RESPIRATORY DISORDERS (2019–2023) 164 FIGURE 36 GERMANY: TRENDS IN UNDER-FIVE MORTALITY RATE 172 FIGURE 37 SPAIN: TRENDS IN UNDER-FIVE MORTALITY RATE (2018–2023) 184 FIGURE 38 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET SNAPSHOT 192 FIGURE 39 JAPAN: MORTALITY RATE IN UNDER-FIVE AGE GROUP 199 FIGURE 40 INDIA: INCIDENCE OF TRACHEA, BRONCHUS, AND LUNG CANCER, BY AGE GROUP (2022 & 2045) 202 FIGURE 41 AUSTRALIA: PREVALENCE OF COPD, BY AGE GROUP (2001–2022) 205 FIGURE 42 AUSTRALIA: TRENDS OVER TIME FOR COPD HOSPITALIZATIONS AMONG PEOPLE AGED 45+ YEARS (2015–16 TO 2021–22) 206 FIGURE 43 GCC COUNTRIES: AGE DEMOGRAPHICS, BY COUNTRY (2023) 220 FIGURE 44 MEDICAL HUMIDIFIER MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD BILLION) 227 FIGURE 45 MEDICAL HUMIDIFIER MARKET SHARE ANALYSIS, 2023 228 FIGURE 46 RANKING OF KEY PLAYERS IN MEDICAL HUMIDIFIER MARKET, 2023 229 FIGURE 47 HEATED HUMIDIFIERS MARKET SHARE, BY KEY PLAYER (2023) 230 FIGURE 48 HEAT & MOISTURE EXCHANGERS MARKET SHARE, BY KEY PLAYER (2023) 231 FIGURE 49 BUBBLE HUMIDIFIERS MARKET SHARE, BY KEY PLAYER (2023) 231 FIGURE 50 MEDICAL HUMIDIFIER MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 233 FIGURE 51 MEDICAL HUMIDIFIER MARKET: COMPANY FOOTPRINT 234 FIGURE 52 MEDICAL HUMIDIFIER MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 238 FIGURE 53 EV/EBITDA OF KEY VENDORS 240 FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 240 FIGURE 55 MEDICAL HUMIDIFIER MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 241 FIGURE 56 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2024) 245 FIGURE 57 RESMED INC.: COMPANY SNAPSHOT (2024) 250 FIGURE 58 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023) 253 FIGURE 59 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023) 257 FIGURE 60 VINCENT MEDICAL HOLDINGS LIMITED: COMPANY SNAPSHOT (2023) 260

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們